1 results  1 of 1 

1 Yttrium-90 ibritumomab tiuxetan plus busulfan, cyclophosphamide, and etoposide (BuCyE) versus BuCyE alone as a conditioning regimen for non-Hodgkin lymphoma
Jae-Cheol Jo, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Chan-Sik Park, Jooryung Huh, Sang-Wook Lee, Jin-Sook Ryu, Cheolwon Suh
Korean J Hematol.2012;47(2):119-125.   Published online 2012 June 26     DOI: http://dx.doi.org/10.5045/kjh.2012.47.2.119
      

 1 of 1